Cargando…

Breast cancer risk-assessment models

There are two main questions when assessing a woman for interventions to reduce her risks of developing or dying from breast cancer, the answers of which will determine her access: What are her chances of carrying a mutation in a high-risk gene such as BRCA1 or BRCA2? What are her risks of developin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, D Gareth R, Howell, Anthony
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242652/ https://www.ncbi.nlm.nih.gov/pubmed/17888188 http://dx.doi.org/10.1186/bcr1750

Ejemplares similares

Can the breast screening appointment be used to provide risk assessment and prevention advice?
por: Evans, D. Gareth, et al.
Publicado: (2015)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

Increased risk of breast cancer in neurofibromatosis type 1: current insights
por: Howell, Sacha J, et al.
Publicado: (2017)

How do women who are informed that they are at increased risk of breast cancer appraise their risk? A systematic review of qualitative research
por: Woof, Victoria G., et al.
Publicado: (2022)

Metaplastic breast cancer and BRCA1: first strong evidence of a link
por: Evans, D. Gareth R, et al.
Publicado: (2023)

Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?
por: Gareth Evans, D, et al.
Publicado: (2004)

Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study
por: French, David P., et al.
Publicado: (2022)

Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancer
por: Pegington, Mary, et al.
Publicado: (2022)

Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
por: Evans, D Gareth R, et al.
Publicado: (2013)

Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway
por: McWilliams, Lorna, et al.
Publicado: (2020)

Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
por: McWilliams, Lorna, et al.
Publicado: (2021)

Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
por: Leventea, Eleni, et al.
Publicado: (2021)

Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting
por: McWilliams, Lorna, et al.
Publicado: (2022)

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
por: Evans, D Gareth, et al.
Publicado: (2008)

Risk determination and prevention of breast cancer
por: Howell, Anthony, et al.
Publicado: (2014)

The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology
por: Lalloo, Fiona, et al.
Publicado: (1999)

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer
por: Evans, D.Gareth, et al.
Publicado: (2021)

Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)

Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss intervention
por: Wright, Claire E, et al.
Publicado: (2015)

Psychological impact of providing women with personalised 10-year breast cancer risk estimates
por: French, David P., et al.
Publicado: (2018)

Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening
por: Woof, Victoria G, et al.
Publicado: (2021)

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
por: Evans, D. Gareth, et al.
Publicado: (2021)

Managing Breast Cancer Risk
por: Ong, Kai Ren, et al.
Publicado: (2005)

The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
por: Basu, Narendra Nath, et al.
Publicado: (2021)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
por: Prosperi, Mattia CF, et al.
Publicado: (2014)

Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom)
por: Renehan, Andrew G., et al.
Publicado: (2020)

Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials
por: Harvie, Michelle, et al.
Publicado: (2019)

Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program
por: Wright, Stuart J., et al.
Publicado: (2023)

Gene panel testing for breast cancer should not be used to confirm syndromic gene associations
por: Evans, D. Gareth, et al.
Publicado: (2018)

Perception of risk in women with a family history of breast cancer.
por: Evans, D. G., et al.
Publicado: (1993)

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography
por: Møller, Pål, et al.
Publicado: (2015)

Breast cancer risk feedback to women in the UK NHS breast screening population
por: Evans, D Gareth R, et al.
Publicado: (2016)

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
por: Evans, D. Gareth, et al.
Publicado: (2021)

Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens
por: Howell, Anthony, et al.
Publicado: (2004)

Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

The impact of genetic counselling on risk perception in women with a family history of breast cancer.
por: Evans, D. G., et al.
Publicado: (1994)

Evaluating the Acceptance and Usability of an App Promoting Weight Gain Prevention and Healthy Behaviors Among Young Women With a Family History of Breast Cancer: Protocol for an Observational Study
por: Pegington, Mary, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pl5m4k505tod96ui7muqk91c2o